HomeCompareVBINX vs JNJ

VBINX vs JNJ: Dividend Comparison 2026

VBINX yields 4.35% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VBINX wins by $6.6K in total portfolio value
10 years
VBINX
VBINX
● Live price
4.35%
Share price
$48.97
Annual div
$2.13
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.6K
Annual income
$575.65
Full VBINX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VBINX vs JNJ

📍 VBINX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVBINXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VBINX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VBINX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBINX
Annual income on $10K today (after 15% tax)
$370.11/yr
After 10yr DRIP, annual income (after tax)
$489.30/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $214.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBINX + JNJ for your $10,000?

VBINX: 50%JNJ: 50%
100% JNJ50/50100% VBINX
Portfolio after 10yr
$23.3K
Annual income
$701.71/yr
Blended yield
3.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VBINX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBINX buys
0
JNJ buys
0
No recent congressional trades found for VBINX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVBINXJNJ
Forward yield4.35%3.36%
Annual dividend / share$2.13$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.6K$20.0K
Annual income after 10y$575.65$827.78
Total dividends collected$5.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VBINX vs JNJ ($10,000, DRIP)

YearVBINX PortfolioVBINX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,135$435.42$10,676$355.77+$459.00VBINX
2$12,368$453.14$11,407$389.39+$961.00VBINX
3$13,704$470.37$12,198$426.53+$1.5KVBINX
4$15,151$487.09$13,056$467.62+$2.1KVBINX
5$16,714$503.27$13,987$513.12+$2.7KVBINX
6$18,403$518.90$14,998$563.56+$3.4KVBINX
7$20,225$533.95$16,098$619.52+$4.1KVBINX
8$22,190$548.43$17,295$681.69+$4.9KVBINX
9$24,305$562.33$18,599$750.82+$5.7KVBINX
10$26,582$575.65$20,022$827.78+$6.6KVBINX

VBINX vs JNJ: Complete Analysis 2026

VBINXStock

The fund employs an indexing investment approach designed to track the performance of two benchmark indexes. With approximately 60% of its assets, the fund seeks to track the investment performance of the CRSP US Total Market Index. With approximately 40% of its assets, the fund seeks to track the investment performance of the BloombergU.S. Aggregate Float Adjusted Index.

Full VBINX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VBINX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBINX vs SCHDVBINX vs JEPIVBINX vs OVBINX vs KOVBINX vs MAINVBINX vs ABBVVBINX vs MRKVBINX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.